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Abstract: 2,4,5-Trisubstituted oxazoles were synthesized in good
yields starting from a-methylene ketones by nitrosation, condensa-
tion with aldehydes and reduction with zinc in acetic acid at 40 °C.
(5-Methyl-2-phenyloxazol-4-yl)ethanol was prepared by reduction
of ethyl (5-methyl-2-phenyloxazol-4-yl)acetate with LiAlH4.
Key words: oxazole, 2,4,5-trisubstituted oxazole, (5-methyl-2-
phenyloxazol-4-yl)ethanol, a-diketone monooxime, condensation
Oxazoles have attracted great interest due to their occur-
rence as subunits of various biologically active natural
products and some drug molecules, as well as their appli-
cations as valuable precursors in many useful synthetic
transformations.1 (5-Methyl-2-phenyloxazol-4yl)ethanol
(1a), a 2,4,5-trisubstituted oxazole, is a key intermediate
of PPAR agonists for treatment of type 2 diabetes and dys-
lipidemic,2 including JTP-20993,3 muraglitazar,4
GW409544,5 GW7845,6 and some other compounds.7
However, the present synthetic approaches to 1a suffer
from low yield, more reaction steps, tedious manipula-
tions in the isolation of products and utilization of toxic
reagents.8 Oxazoles are commonly prepared from inter-
mediates such as a-halo ketones,9 a-diazo ketones,10 a-
acyloxy ketones,11 and a-acylamino ketones.12 However,
preparations of these reactive intermediates are not al-
ways straightforward because of various drawbacks en-
countered, such as long reaction times, low yields, and
forced reaction conditions. Although there are many use-
ful synthetic methods reported for the preparation of sub-
stituted oxazoles, practical and convenient methods for
the synthesis of 2,4,5-trisubstituted oxazoles have been
quite limited.13,14 Therefore, development of a more con-
venient and efficient method for the synthesis of multi-
substituted oxazoles is of prime necessity.
Here we describe a simple procedure for the synthesis of
2,4,5-trisubstituted oxazole 5 in higher yields (Table 1) by
reduction of unstable intermediate 4 with zinc or catalytic
hydrogenation. The N-oxides 4 could be obtained by con-
densation of aldehyde and a-diketone monooxime 3 in
acetic acid saturated by dry HCl gas (Scheme 1). Interme-
diates 3 could easily be prepared by treating a-methylene
ketones 2 with methyl nitrite in diethyl ether saturated by
dry HCl gas at room temperature. 
Scheme 1 Reagents and conditions: a) MeONO, dry HCl, Et2O, r.t.;
b) dry HCl, AcOH; c) AcOH, Zn, 40 °C, 0.5 h or Pd/C, H2, MeOH,
r.t.; d) Et2O, LiAlH4, 93%.
In conclusion, a simple and attractive procedure for the
synthesis of 2,4,5-trisubstituted oxazoles was developed
in good yields. This procedure is effective, including easy
work-up, shorter reaction time, higher yield and avoid-
ance of hazardous reagents.
All starting compounds were used as received from commercial
sources without further purification. Melting points were deter-
mined on XRC-1 micromelting point apparatus and are uncorrected.
Column chromatography was carried out on silica gel (200–300
mesh, Qingdao Haiyang Chemical Co. Ltd.). 1H NMR and 13C
NMR spectra were recorded on a Bruker Avance 600 spectrometer
with TMS as internal standard. ESI-MS and IR spectra were ob-
tained on a Finnigan LCQDECA and a Perkin-Elmer spectrum one
FT-IR spectrometer (KBr disc), respectively.
a-Diketone Monooximes 3a–e; General Procedure
Methyl nitrite (2.95 g, 45 mmol) was bubbled through a solution of
an appropriate a-methylene ketone 2 (30 mmol) in Et2O (40 mL)
Table 1 Synthesis of a-Diketone Monooximes 3 and 2,4,5-Trisub-
stituted Oxazoles 5 
R1 R2 R3 Products Yields (%)a
Me CH2CO2Et Ph 3a, 5a 80, 76
Me Me Ph 3b, 5b 83, 85
Me COCH3 Ph 3c, 5c 74, 88
Ph Me Ph 3d, 5d 74, 81
Me CO2Et Ph 3e, 5e 78, 90
Me CO2Et 2-furyl 3e, 5f –, 84
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saturated with dry HCl gas at r.t. The reaction mixture was stirred
for 2 h. After completion of the reaction (monitored by TLC), H2O
(50 mL) was added, the organic layer was separated, and the aque-
ous layer was extracted with Et2O. The combined organic layers
were washed with H2O and brine, and dried (Na2SO4). After con-
centration, the residue was purified by silica gel column chromatog-
raphy [petroleum ether (bp 60–90 °C)–EtOAc, 12: 1] to give 3a, or
recrystallized from toluene, for 3b–e (Table 1).
Ethyl 3-Hydroxyimino-4-oxopentanoate (3a)
Yield: 4.15 g (80%) (Lit.15 yield: 60%); yellow oil.
IR (KBr): 3338, 2987, 2922, 2874, 1739, 1694, 1629, 1438, 1369,
1344, 1179, 1106, 1003 cm–1.
IH NMR (CDCl3): d = 1.31 (t, J = 7.1 Hz, 3 H), 1.90 (br s, 1 H), 2.10
(s, 2 H), 2.25 (s, 3 H), 4.14 (q, J = 7.1 Hz, 2 H).
I3C NMR (CDCl3): d = 14.2, 21.8, 32.2, 59.7, 164.3, 166.5, 197.7.
ESI-MS: m/z (%) = 196 ([M + Na+], 72), 173 ([M+], 13), 158 ([M –
CH3]+, 16), 144 ([M –CH2CH3]+, 30).
3-Hydroxyiminobutan-2-one (3b)
Yield: 2.51 g (83%); colorless crystals; mp 74–75 °C (Lit.15 mp 75–
76 °C). 
3-Hydroxyiminopentane-2,5-dione (3c)
Yield: 2.86 g (74%); colorless crystals; mp 69–70 °C (Lit.16 mp 72–
73 °C). 
2-Hydroxyimino-1-phenylpropanone (3d)
Yield: 3.61 g (74%); colorless crystals; mp 112–113 °C (Lit.17 mp
113–115 °C).
Ethyl 2-Hydroxyimino-3-oxobutyrate (3e)
Yield: 3.72 g (78%); white crystals; mp 57–58 °C.
IR (KBr): 3324, 2972, 2942, 2874, 1736, 1676, 1629, 1373, 1317,
1254, 1157, 1076, 958, 857, 723 cm–1. 
1H NMR (CDCl3): d = 1.33 (t, J = 7.0 Hz, 3 H), 1.92 (br s, 1 H), 2.28
(s, 3 H), 4.15 (q, J = 7.0 Hz, 2 H).
I3C NMR (CDCl3): d = 14.0, 21.6, 60.3, 162.5, 163.4, 198.2.
ESI-MS: m/z (%) = 158 ([M – H]–, 65), 159 ([M–], 5).
Oxazoles 5a–g; General Procedure
A solution of a-diketone monooxime 3 (3 mmol) and the corre-
sponding aldehyde (3.3 mmol) in AcOH (15 mL) was cooled to 0–
5 °C, and dry HCl gas was bubbled through the reaction mixture for
0.5 h. The mixture was stirred at the same temperature for 2 h and
was diluted with Et2O (45 mL). The white solid intermediate 4 was
filtered and washed with Et2O (10 mL). It was then dissolved in
AcOH (5 mL), and zinc (0.390 g, 6 mmol) was added. The mixture
was stirred at 40 °C for 0.5 h, and H2O (40 mL) was added to the
mixture. The mixture was extracted with Et2O, and the organic layer
was washed with H2O and brine, and dried (Na2SO4). The solvent
was removed to give 5 (Table 1). 
Ethyl (5-Methyl-2-phenyloxazol-4-yl)acetate (5a)
Yield: 0.559 g (76%); yellow oil. 
IR (KBr): 3063, 2983, 2926, 1739, 1643, 1555, 1488, 1449, 1370,
1204, 1161, 1027, 878, 776, 692 cm–1.
IH NMR (CDCl3): d = 1.28 (t, J = 7.1 Hz, 3 H), 2.38 (s, 3 H), 3.57
(s, 2 H), 4.20 (q, J = 7.1 Hz, 2 H), 7.40–7.45 (m, 3 H), 7.99 (dd,
J = 8.1, 1.5 Hz, 2 H). 
I3C NMR (CDCl3): d = 12.5, 14.4, 28.7, 60.2, 125.3, 128.5, 129.2,
130.4, 156.4, 159.6, 163.2.
ESI-MS: m/z (%) = 268 ([M + Na+], 100), 273 ([M + K+], 41), 246
([M + H]+,19), 172 ([M – CH2CO2Et]+, 24).
Alternative Method for 5a: A solution of 3a (1.73 g, 10 mmol) and
benzaldehyde (1.16 g, 11 mmol) in AcOH (15 mL) was cooled to
0–5 °C, and dry HCl gas was bubbled into the reaction mixture for
1 h. The mixture was stirred at r.t. for 2 h and then diluted with Et2O
(40 mL). The white solid was filtered, washed with Et2O (10 mL)
and then dissolved in MeOH (15 mL). The mixture was hydrogenat-
ed with 5% Pd/C (0.14 g) under atmospheric pressure at r.t. for 4 h.
The catalyst was filtered off and washed with a small amount of
MeOH. The combined filtrates were concentrated in vacuo to yield
5a; yield: 1.76 g (72%); yellow oil.
4,5-Dimethyl-2-phenyloxazole (5b)
Yield: 0.441 g (85%); white solid; mp 43–45 °C.
IR (KBr): 3059, 2924, 1642, 1612, 1553, 1488, 1449, 1339, 1240,
1153, 1068, 948, 754, 774, 711, 691 cm–1.
1H NMR (CDCl3): d = 2.17 (s, 3 H), 2.30 (s, 3 H), 7.40–7.45 (m, 3
H), 7.99 (dd, J = 8.3 Hz, 1.5 Hz, 2 H).
I3C NMR (CDCl3): d = 10.1, 11.3, 125.8, 127.8, 128.7, 129.6,
131.9, 143.4, 159.1.
ESI-MS: m/z (%) = 212 ([M + K+], 8), 174 ([M + H]+, 100).
4-Acetyl-5-methyl-2-phenyloxazole (5c)
Yield: 0.531 g (88%); white solid, mp 71–73 °C.
IR (KBr): 3055, 3002, 2933, 1684, 1596, 1483, 1450, 1380, 1355,
1195, 1074, 955, 934, 778, 713, 690 cm–1.
1H NMR (CDCl3): d = 2.61 (s, 3 H), 2.70 (s, 3 H), 7.46–7.48 (m, 3
H), 8.04 (dd, J = 8.0, 1.6 Hz, 2 H).
I3C NMR (CDCl3): d = 12.4, 27.9, 126.4, 126.9, 128.8, 130.6,
135.8, 154.5, 158.7, 195.4.
ESI-MS: m/z = 202 ([M + H]+, 70%).
4-Methyl-2,5-diphenyloxazole (5d)
Yield: 0.572 g (81%); white solid; mp 75–77 °C.
IR (KBr): 3053, 2930, 1685, 1615, 1552, 1472, 1435, 1354, 1245,
1074, 1014, 955, 912, 772, 712, 690 cm–1.
1H NMR (CDCl3): d = 2.51 (s, 3 H), 7.33–7.35 (m, 1 H), 7.45–7.49
(m, 5 H), 7.70 (dd, J = 7.9 Hz, 2 H), 8.09 (d, J = 7.3 Hz, 2 H).
I3C NMR (CDCl3): d = 13.5, 125.4, 126.2, 127.4, 127.7, 128.7,
128.9, 129.2, 130.2, 133.4, 145.5, 159.4.
ESI-MS: m/z = 236 ([M + H]+, 100%).
Ethyl (5-Methyl-2-phenyloxazol-4-yl)carboxylate (5e)
Yield: 0.624 g (90%); colorless oil.
IR (KBr): 3050, 2977, 2875, 1715, 1615, 1563, 1449, 1372, 1342,
1237, 1186, 1105, 1057, 786, 710, 691 cm–1.
1H NMR (CDCl3): d = 1.43 (t, J = 7.1 Hz, 3 H), 2.73 (s, 3 H), 4.45
(q, J = 7.1 Hz, 2 H), 7.46–7.48 (m, 3 H), 8.08 (dd, J = 7.7, 1.6 Hz,
2 H).
I3C NMR (CDCl3): d = 12.3, 14.4, 60.1, 126.6, 128.7, 128.9, 130.7,
156.2, 159.7, 162.5.
ESI-MS: m/z (%) = 270 ([M + K+], 15), 254 ([M + Na+], 100), 232
([M + H]+, 3).
Ethyl (2-Furyl-5-methyloxazol-4-yl)carboxylate (5f)
Yield: 0.557 g (84%); yellow solid; mp 80–82 °C.
IR (KBr): 3144, 3121, 2984, 2931, 1731, 1643, 1628, 1599, 1547,
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1H NMR (CDCl3): d = 1.41 (t, J = 7.0 Hz, 3 H), 2.70 (s, 3 H), 4.41
(q, J = 7.1 Hz, 2 H), 6.54 (m, J = 1.5 Hz, 1 H), 7.10 (d, J = 3.42 Hz,
1 H), 7.58 (s, 1 H). 
I3C NMR (CDCl3): d = 12.1, 14.4, 61.1, 111.9, 112.3, 128.6, 142.1,
144.7, 152.3, 155.7, 162.2.
ESI-MS: m/z (%) = 260 ([M + K+], 19), 244 ([M + Na+], 100), 222
([M + H]+, 3).
Ethyl (2-Isopropyl-5-methyloxazol-4-yl)carboxylate (5g)
Yield: 0.505 g (93%); yellow oil.
IR (KBr): 2970, 2875, 2823, 1712, 1610, 1540, 1472, 1350, 1230,
1177, 1105, 1059, 1010, 792, 728, 693 cm–1.
1H NMR (CDCl3): d = 1.34 (d, J = 7.0 Hz, 6 H), 1.40 (t, J = 7.1 Hz,
3 H), 2.60 (s, 3 H), 3.10 (m, 1 H), 4.43 (q, J = 7.1 Hz, 2 H).
I3C NMR (CDCl3): d = 12.0, 14.4, 20.3, 28.4, 60.8, 127.1, 155.8,
162.6, 166.9.
ESI-MS: m/z (%) = 236 ([M + K+], 7), 220 ([M + Na+], 26), 198 ([M
+ H]+, 100). 
(5-Methyl-2-phenyloxazol-4-yl)ethanol (1a)
A solution of 5a (1.23 g, 5 mmol) in Et2O (30 mL) was added to a
stirred and ice-cooled suspension of LiAlH4 (0.185 g, 5 mmol) in
Et2O (100 mL). The mixture was stirred at r.t. for 1 h, cooled in an
ice bath, and aq 2 M HCl (15 mL) was added dropwise. The organic
layer was separated and the aqueous layer was extracted with Et2O.
The combined organic layers were washed with brine, dried
(Na2SO4). The solvent was removed in vacuo to afford 1a; yield:
0.943 g (93%); white powder; mp 72–73 °C (Lit.8e mp 73–74 °C). 
IR (KBr): 3304, 3059, 2942, 2901, 2872, 1647, 1555, 1486, 1428,
1338, 1222, 1133, 1053, 777, 721, 691 cm–1.
1H NMR (CDCl3): d = 2.36 (s, 3 H), 2.75 (t, J = 5.9 Hz, 2 H), 3.20
(br s, 1 H), 3.95 (t, J = 5.8 Hz, 2 H), 7.42–7.46 (m, 3 H), 7.98 (dd,
J = 8.1, 1.5 Hz, 2 H).
I3C NMR (CDCl3): d = 10.1, 28.0, 61.9, 125.9, 127.5, 128.7, 130.0,
134.9, 144.1, 159.6.
ESI-MS: m/z (%) = 226 ([M + Na+], 32), 204 ([M + H]+, 100), 186
([M – OH]+, 26).
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